Cargando…

Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors

Conventional methods to measure ligand-receptor binding parameters typically require radiolabeled ligands as probes. Despite the robustness of radioligand binding assays, they carry inherent disadvantages in terms of safety precautions, expensive synthesis, special lab requirements, and waste dispos...

Descripción completa

Detalles Bibliográficos
Autores principales: Massink, A., Holzheimer, M., Hölscher, A., Louvel, J., Guo, D., Spijksma, G., Hankemeier, T., IJzerman, A. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648803/
https://www.ncbi.nlm.nih.gov/pubmed/26482925
http://dx.doi.org/10.1007/s11302-015-9477-0
_version_ 1782401274714521600
author Massink, A.
Holzheimer, M.
Hölscher, A.
Louvel, J.
Guo, D.
Spijksma, G.
Hankemeier, T.
IJzerman, A. P.
author_facet Massink, A.
Holzheimer, M.
Hölscher, A.
Louvel, J.
Guo, D.
Spijksma, G.
Hankemeier, T.
IJzerman, A. P.
author_sort Massink, A.
collection PubMed
description Conventional methods to measure ligand-receptor binding parameters typically require radiolabeled ligands as probes. Despite the robustness of radioligand binding assays, they carry inherent disadvantages in terms of safety precautions, expensive synthesis, special lab requirements, and waste disposal. Mass spectrometry (MS) is a method that can selectively detect ligands without the need of a label. The sensitivity of MS equipment increases progressively, and currently, it is possible to detect low ligand quantities that are usually found in ligand binding assays. We developed a label-free MS ligand binding (MS binding) assay on the adenosine A(1) and A(2A) receptors (A(1)AR and A(2A)AR), which are well-characterized members of the class A G protein-coupled receptor (GPCR) family. Radioligand binding assays for both receptors are well established, and ample data is available to compare and evaluate the performance of an MS binding assay. 1,3-Dipropyl-8-cyclopentyl-xanthine (DPCPX) and 4-(2-((7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a]-[1,3,5]triazin-5-yl)amino)ethyl)phenol (ZM-241,385) are high-affinity ligands selective for the A(1)AR and A(2A)AR, respectively. To proof the feasibility of MS binding on the A(1)AR and A(2A)AR, we first developed an MS detection method for unlabeled DPCPX and ZM-241,385. To serve as internal standards, both compounds were also deuterium-labeled. Subsequently, we investigated whether the two unlabeled compounds could substitute for their radiolabeled counterparts as marker ligands in binding experiments, including saturation, displacement, dissociation, and competition association assays. Furthermore, we investigated the accuracy of these assays if the use of internal standards was excluded. The results demonstrate the feasibility of the MS binding assay, even in the absence of a deuterium-labeled internal standard, and provide great promise for the further development of label-free assays based on MS for other GPCRs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11302-015-9477-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4648803
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-46488032015-11-24 Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors Massink, A. Holzheimer, M. Hölscher, A. Louvel, J. Guo, D. Spijksma, G. Hankemeier, T. IJzerman, A. P. Purinergic Signal Original Article Conventional methods to measure ligand-receptor binding parameters typically require radiolabeled ligands as probes. Despite the robustness of radioligand binding assays, they carry inherent disadvantages in terms of safety precautions, expensive synthesis, special lab requirements, and waste disposal. Mass spectrometry (MS) is a method that can selectively detect ligands without the need of a label. The sensitivity of MS equipment increases progressively, and currently, it is possible to detect low ligand quantities that are usually found in ligand binding assays. We developed a label-free MS ligand binding (MS binding) assay on the adenosine A(1) and A(2A) receptors (A(1)AR and A(2A)AR), which are well-characterized members of the class A G protein-coupled receptor (GPCR) family. Radioligand binding assays for both receptors are well established, and ample data is available to compare and evaluate the performance of an MS binding assay. 1,3-Dipropyl-8-cyclopentyl-xanthine (DPCPX) and 4-(2-((7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a]-[1,3,5]triazin-5-yl)amino)ethyl)phenol (ZM-241,385) are high-affinity ligands selective for the A(1)AR and A(2A)AR, respectively. To proof the feasibility of MS binding on the A(1)AR and A(2A)AR, we first developed an MS detection method for unlabeled DPCPX and ZM-241,385. To serve as internal standards, both compounds were also deuterium-labeled. Subsequently, we investigated whether the two unlabeled compounds could substitute for their radiolabeled counterparts as marker ligands in binding experiments, including saturation, displacement, dissociation, and competition association assays. Furthermore, we investigated the accuracy of these assays if the use of internal standards was excluded. The results demonstrate the feasibility of the MS binding assay, even in the absence of a deuterium-labeled internal standard, and provide great promise for the further development of label-free assays based on MS for other GPCRs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11302-015-9477-0) contains supplementary material, which is available to authorized users. Springer Netherlands 2015-10-19 2015-12 /pmc/articles/PMC4648803/ /pubmed/26482925 http://dx.doi.org/10.1007/s11302-015-9477-0 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Massink, A.
Holzheimer, M.
Hölscher, A.
Louvel, J.
Guo, D.
Spijksma, G.
Hankemeier, T.
IJzerman, A. P.
Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors
title Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors
title_full Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors
title_fullStr Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors
title_full_unstemmed Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors
title_short Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors
title_sort mass spectrometry-based ligand binding assays on adenosine a(1) and a(2a) receptors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648803/
https://www.ncbi.nlm.nih.gov/pubmed/26482925
http://dx.doi.org/10.1007/s11302-015-9477-0
work_keys_str_mv AT massinka massspectrometrybasedligandbindingassaysonadenosinea1anda2areceptors
AT holzheimerm massspectrometrybasedligandbindingassaysonadenosinea1anda2areceptors
AT holschera massspectrometrybasedligandbindingassaysonadenosinea1anda2areceptors
AT louvelj massspectrometrybasedligandbindingassaysonadenosinea1anda2areceptors
AT guod massspectrometrybasedligandbindingassaysonadenosinea1anda2areceptors
AT spijksmag massspectrometrybasedligandbindingassaysonadenosinea1anda2areceptors
AT hankemeiert massspectrometrybasedligandbindingassaysonadenosinea1anda2areceptors
AT ijzermanap massspectrometrybasedligandbindingassaysonadenosinea1anda2areceptors